Oramed Pharmaceuticals (ORMP) Change in Account Payables (2010 - 2024)

Oramed Pharmaceuticals (ORMP) has 13 years of Change in Account Payables data on file, last reported at $1.5 million in Q3 2024.

• Quarterly Change in Account Payables fell 10.42% year-over-year to $1.5 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $2.5 million (up 651.79% YoY) and the FY2023 annual result came in at -$2.2 million, down 491.76% from the prior year.
• Change in Account Payables declined to $1.5 million in Q3 2024, from $2.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.2 million in Q2 2024 to a low of -$3.2 million in Q2 2023.
• A 3-year average of $174727.3 and a median of $389000.0 in 2020 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 322.83% in 2020, down 1009.82% in 2020.
• Tracing ORMP's Change in Account Payables over 3 years: stood at $1.2 million in 2020, then sank by 154.12% to -$624000.0 in 2023, then jumped by 347.92% to $1.5 million in 2024.
• The last three Change in Account Payables figures came in at $1.5 million (Q3 2024), $2.2 million (Q2 2024), and -$666000.0 (Q1 2024), per Business Quant data.